Risk factors for thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study
The DOI matches its OpenAlex record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
As previously reported, 1007 patients with chronic atrial fibrillation participated in the Copenhagen AFASAK study. Before inclusion to trial, they all had a physical examination, chest roentgenogram, and echocardiogram with determination of left atrial size. This study evaluated the importance of cardiovascular risk factors for development of thromboembolic complications. To exclude any treatment effects on occurrence of thromboembolic complications, we included only the 336 patients from the placebo group. Using Cox's regression model, previous myocardial infarction was a significant risk factor for development of thromboembolic complications. Age, gender, heart failure, chest pain, hypertensive heart disease, diabetes, systolic and diastolic blood pressure, smoking, relative heart volume, and left atrial size were all without statistical importance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study
Wolf, P. A., Dawber, T. R., Thomas, H. E., & Kannel, W. B. (1978) · Neurology · doi:10.1212/wnl.28.10.973 · Cited by 1,526
Atrial fibrillation and stroke: new ideas, persisting dilemmas
Halperin, J. L., & Hart, R. G. (1988) · Stroke · doi:10.1161/01.str.19.8.937 · Cited by 231
Cited by
Stroke Prevention in Atrial Fibrillation Study. Final results.
(1991) · Circulation · doi:10.1161/01.cir.84.2.527 · Cited by 1,696
Left Atrial Size and the Risk of Stroke and Death: The Framingham Heart Study
Benjamin, E. J., D’Agostino, R. B., Belanger, A. J., Wolf, P. A., & Levy, D. (1995) · Circulation · doi:10.1161/01.cir.92.4.835 · Cited by 1,055
Prystowsky, E. N., Benson, D. W., Fuster, V., Hart, R. G., Kay, G. N., Myerburg, R. J., Naccarelli, G. V., & Wyse, D. G. (1996) · Circulation · doi:10.1161/01.cir.93.6.1262 · Cited by 635
The Stroke Prevention in Atrial Fibrillation Investigators (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-6 · Cited by 543
Best method in clinical practice and in research studies to determine left atrial size
Lester, S. J., Ryan, E. W., Schiller, N. B., & Foster, E. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00446-4 · Cited by 535
Predictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at Risk
The Stroke Prevention in Atrial Fibrillation Investigators (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-1 · Cited by 477
Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0508 · Cited by 371
Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S. D., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0443 · Cited by 365
Prognostic implications of left artial spontaneous echo contrast in nonvalvular atrial fibrillation
Leung, D. Y. C., Black, I. W., Cranney, G. B., Hopkins, A. P., & Walsh, W. F. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90025-6 · Cited by 365
Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0403 · Cited by 364
Gage, B. F. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530230025025 · Cited by 329
Gitter, M. J., Jaeger, T. M., Petterson, T. M., Gersh, B. J., & Silverstein, M. D. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.8.725 · Cited by 276
Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention
Hart, R. G., & Halperin, J. L. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-9-199911020-00010 · Cited by 269
Age as a Risk Factor for Stroke in Atrial Fibrillation Patients
Marinigh, R., Lip, G. Y. H., Fiotti, N., Giansante, C., & Lane, D. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.028 · Cited by 232
“#) n Age Criteria Flegel and Hanley, 1989 (25) 91 Age 75 yrs Cabin et al., 1990 (24) 272 Age 70 yrs Petersen et al., 1990 (12) 336 Correlation with in Wolf et al., 1991 (1) 5,070 Age 80–90 yrs Moulton et al., 1991 (22) 2,516 Age 75 yrs SPAF Investigators, 1992 (19) 568 Incremental risk p AFI, 1994…”
Aronow, W. S., Ahn, C., Kronzon, I., & Gutstein, H. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00247-1 · Cited by 74
Metadata
- Authors
- Petersen, P.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1990-04-01
- Volume
- 150
- Issue
- 4
- Pages
- 819-821
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W4235421336
- Cited by
- 129
- References
- 2
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.